Thyroid cancer and thyroiditis in Salta, Argentina: a 40-yr study in relation to iodine prophylaxis.
The natural history of thyroid cancer and thyroiditis in relation to iodine prophylaxis in the region of Salta, Argentina, where goiter is common was investigated over a time span of 40 yr. For analysis of thyroid cancer, the specimens were divided into two periods. The first 15 yr (59 cases), including 5 yr before prophylaxis, was compared with the second 25 yr (182 cases), a period well after salt iodination. Papillary carcinomas formed the largest group of tumors in both periods, with a significant increase in their proportion in the second period (44 vs 60%, chi(2): p < 0.05), while the percentage of follicular and undifferentiated carcinomas decreased and medullary carcinoma remained about the same. The ratio of papillary to follicular carcinoma rose from 1.7:1 in the first period to 3.1:1 in the second. Four thyroid lymphomas of non-Hodgkin's B-cell type occurred in the second period in females over age 50. A severe lymphoid thyroiditis was present in the two cases with assessable background thyroid tissue. The frequency of moderate to severe lymphoid infiltrate in females rose from 2 of 12 (16.6%) in the preprophylaxis period to 34 of 114 (28.0%) in the last 25 yr after prophylaxis. After salt prophylaxis, thyroiditis was more frequent in patients with papillary carcinoma (36.2%) than in those with nonpapillary tumors (14.7%) (chi(2), p < 0.02). These observations indicate that a high dietary intake of iodine may be associated with a high frequency of papillary carcinoma and thyroiditis, and that thyroiditis is more commonly associated with papillary carcinoma than with other thyroid tumors. The occurrence of non-Hodgkin's lymphomas only in the postprophylaxis period may be linked to an increase in thyroiditis.
Harach
H Rubén
HR
Services of Pathology, Dr A Oñativia Endocrinology and Metabolism Hospital, Salta, Argentina. rubenharach@ciudad.com.ar
Escalante
Dardo A
DA
Day
Ernesto Saravia
ES
D000328:Adult; D001118:Argentina / Q000453:epidemiology; D002277:Carcinoma / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D004032:Diet; D005260:Female; D006043:Goiter, Endemic / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007455:Iodine / Q000008:administration & dosage* / Q000172:deficiency; D016393:Lymphoma, B-Cell / Q000453:epidemiology* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D013964:Thyroid Neoplasms / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control; D013967:Thyroiditis, Autoimmune / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control
D007455:Iodine